Michael Jacobs, MD
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $83,075 of the $105,607 with a category attached, or 78.7%. AbbVie accounts for 87.5% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2019 at $31,955 and has fallen 54.1% since, to $14,671 in 2025. Among surgery clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 192 payments — averaging $550.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$92K
- Intuitive Surgical$12K
- TELA Bio, Inc.$381
- Medtronic$170
- Dilon Technologies, Inc.$141
- Aimmune Therapeutics, Inc.$140
- plus $795 from 15 others
Across 7 payments — averaging $2383.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$17K
What the payments were for
- Speaking & faculty fees$83,07579%
- Travel & lodging$7,6767%
- Food & beverage$5,0855%
- Education$9,7709%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 108 | $92,404 |
| Intuitive Surgical | 32 | $11,576 |
| TELA Bio, Inc. | 7 | $381 |
| Medtronic | 3 | $170 |
| Dilon Technologies, Inc. | 1 | $141 |
| Aimmune Therapeutics, Inc. | 7 | $140 |
| Nestle Healthcare Nutrition Inc. | 6 | $127 |
| Vivus LLC | 6 | $110 |
| Integra Lifesciences Corporation | 4 | $109 |
| Stryker | 1 | $70 |
| Acera Surgical, Inc. | 3 | $61 |
| AstraZeneca | 3 | $53 |
| Heron Therapeutics, Inc. | 2 | $50 |
| Eisai Inc. | 2 | $40 |
| Davol Inc. | 1 | $35 |
| W. L. Gore & Associates, Inc. | 1 | $33 |
| Johnson & Johnson | 1 | $29 |
| Medical Device Business Services, Inc. | 1 | $24 |
| CSL Behring | 1 | $20 |
| Clovis Oncology, Inc. | 1 | $17 |
| Mesh Suture Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Creon$25,888
- Da Vinci Surgical System$6,978
- DAVINCI XI$3,750
- HemoBlast Bellows$141
- OviTex 2S$118
- Signia$115
How this compares
$105,607 in reported general payments places this provider in the 95th percentile of 1,081 surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 101 | $333,517 |
| ZenpepLipase/Protease/Amylase | 22 | $86,082 |
| Pantoprazole Sodium | 87 | $1,061 |
| Famotidine | 40 | $793 |
| Sucralfate | 18 | $706 |
| Omeprazole | 14 | $252 |
| Cephalexin | 14 | $58 |
| Ciprofloxacin Hcl | 11 | $57 |
| Metoclopramide Hcl | 18 | $56 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $38 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $32 |
| Dexamethasone | 14 | $7 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon | $92,404 | $333,517101 claims |
| Aimmune Therapeutics, Inc.Zenpep | $140 | $86,08222 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,081 surgery providers in Michigan.
Other surgery in Novi
- Robert BartlettAnn Arbor$859K
- Matthew FourmanMonroe$492K
- Bruce McIntoshRochester Hills$435K
- Jon SchramZeeland$261K
- Eric DaviesBrighton$258K
- Robert LyonsYpsilanti$196K
- Joel StrehlTraverse City$170K
- John LimClinton Township$141K
- Bellal JosephDetroit$114K
- Anthony IaccoBeverly Hills$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.